Advertisement

Catalent Pharma Solutions, Inc. Company Profile

12:25 EDT 24th May 2013 | BioPortfolio

Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,000 at 30 facilities worldwide and in fiscal 2009 generated more than $1.6 billion of annual revenue. For more information, visit www.catalent.com.


News Articles [ 1395 Associated News Articles listed on BioPortfolio]

New Issue-Catalent Pharma Solutions sells $350 mln notes

Sept 5 (Reuters) - Catalent Pharma Solutions Inc on Wednesday sold $350 million of senior notes in the 144a private placement market, said IFR, a Thomson Reuters service. The size of the deal wa...

Catalent, UMN Pharma collaborate on biosimilar development, production in Japan

Catalent Pharma Solutions, a Somerset, N.J.-based developer of solutions and drug delivery technology, has signed an agreement to provide UMN Pharma, a Japanese pharmaceutical company, a broad range o...

Catalent and UMN Pharma Announce Collaboration for Biosimilar Development and Production in Japan

Catalent Pharma Solutions and UMN Pharma Inc. today announced the signing of an agreement to provide UMN Pharma a broad range of biosimilar cell lines using Catalent’s proprietary GPEx ® techno...

Catalent and UMN Pharma collaborate for biosimilars development and production in Japan

Privately-held USA-based Catalent Pharma Solutions and Japanese drugmaker UMN Pharma (TYO Mothers: 4585) have signed an agreement to provide UMN Pharma a broad range of biosimilar cell lines using Cat...

UMN Pharma to produce biosimilars cell lines using Catalent GPEx technology

UMN Pharma has entered into a collaboration agreement with Catalent Pharma Solutions for the development and production of biosimilar cell lines.

UMN taps Catalent tech as it eyes biosimilar production, alliances for Asia

No sooner had the Japanese vaccines venture UMN Pharma listed on the Tokyo Stock Exchange than it struck its first post-IPO deal, linking up with Catalent Pharma Solutions for technology for the man...

Catalent and Bend Research partner to provide integrated solutions for oral controllled release technologies

Published date:  21/06/2012 Summary:  . Somerset, NJ and Bend, O...

Catalent Pharma launches Catalent Applied Drug Delivery Institute

Catalent Pharma Solutions, a developer of solutions and advanced drug delivery technologies, has launched its Catalent Applied Drug Delivery Institute.

Drugs and Medications [ 432 Associated Drugs and Medications listed on BioPortfolio]

Chlorothiazide sodium [Sun Pharma Global FZE]

Chlorothiazide Sodium for Injection, USPFOR THE PREPARATION OF INTRAVENOUS SOLUTIONS

Robitussin cough gels long-acting [Richmond Division of Wyeth]

Robitussin CoughGels Long-Acting (dextromethorphan HBr)

Advil [Pfizer Consumer Healthcare]

Advil Liqui-Gels (ibuprofen)

Advil pm [Pfizer Consumer Healthcare]

Advil PM Liqui-Gels (diphenhydramine HCl and ibuprofen)

Robitussin lingering cold long-acting coughgels [Richmond Division of Wyeth]

Robitussin Lingering Cold Long-Acting CoughGels(dextromethorphan HBr)

PubMed Articles [ 337 Associated PubMed Articles listed on BioPortfolio]

Comment about the article "Psychopharmaceuticals and diabetes" of Ress C, Tschoner A, Kaser S, and Ebenbichler CF in Wiener Medizinische Wochenschrift 2011; 161/21-22: 531-42.

Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.

Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...

Aha! experiences leave a mark: facilitated recall of insight solutions.

The present study investigates a possible memory advantage for solutions that were reached through insightful problem solving. We hypothesized that insight solutions (with Aha! experience) would be re...

Is pharma running out of brainy ideas?

Big pharma moves from 'blockbusters' to 'niche busters'.

Clinical Trials [ 152 Associated Clinical Trials listed on BioPortfolio]

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone

To compare the effectiveness of a 90-day Copaxone® adherence enhancement program for a sample of MS patients who are at high risk of nonadherence and receive support from Shared Solutions...

Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness

Obesity is increasing at an alarming rate in patients with schizophrenia, possibly in association with the increased use of atypical antipsychotics. In order to address the weight and meta...

Palatability of Oral Rehydration Solutions

The primary objective of this study is to compare the mean taste scores for three fruit flavored oral rehydration solutions in children aged 5-10 years old. The secondary objective is to...

Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne

This study investigates the safety and efficacy of MBI 226 2.5% and 5.0% Acne Solutions, applied topically for six weeks, in the treatment of acne.

Complete Easy Rub Comparative Efficacy Study

The aim of this trial is to assess Complete Easy Rub compared to a competitor multi-purpose solution in terms of lens cleanliness, subjective response and ocular response, when lenses are...

Companies [ 1699 Associated Companies listed on BioPortfolio]

Catalent Pharma Solutions, Inc.

Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced technologies, and development, manufacturing and packaging services for pharmace...

Catalent Applied Drug Delivery Institute

The mission of the Catalent Applied Drug Delivery Institute is to promote collaboration between industry and academia, provide applied drug delivery education and training, and ac...

ERYtech Pharma

ERYtech Pharma is a specialty pharma company developing innovative therapeutic solutions based on its proprietary technology and expertise in the physiological properties of eryth...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

More Information about "Catalent Pharma Solutions, Inc." on BioPortfolio

We have published hundreds of Catalent Pharma Solutions, Inc. news stories on BioPortfolio along with dozens of Catalent Pharma Solutions, Inc. Clinical Trials and PubMed Articles about Catalent Pharma Solutions, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalent Pharma Solutions, Inc. Companies in our database. You can also find out about relevant Catalent Pharma Solutions, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement